HIV NEWS, CONFERENCES AND EVENTS
Our Media centre contains a range of resources including our latest and archived press releases and news updates, conferences and events we attend, our image and video library and social media information.
These press releases and news updates are intended for media and investors only
LATEST PRESS RELEASES
-
ViiV Healthcare announces label update for its long-acting HIV treatment, Cabenuva (cabotegravir, rilpivirine), to be initiated with or without an oral lead-in period
24 Mar 2022ViiV Healthcare announces label update for its long-acting HIV treatment, Cabenuva (cabotegravir, rilpivirine), to be initiated with or without an oral lead-in periodRead more »
LATEST NEWS UPDATES
CONFERENCES AND EVENTS
FEBRUARY 2022
The Conference on Retroviruses and Opportunistic Infections (CROI) is one of the most eagerly anticipated HIV events of the year. Bringing together the most respected infectious disease healthcare professionals and researchers from around the globe, CROI is one of the world’s most prestigious congresses in this field.
27–30 OCTOBER 2021
ViiV Healthcare joined the 18th European AIDS Conference to present to present new findings in HIV treatment and prevention, sharing the latest data across our diverse portfolio and pipeline of medicines that aim to address the evolving needs of the HIV community.
29 SEPTEMBER-3 OCTOBER 2021
ViiV Healthcare joined IDWeek 2021 to present new findings in HIV treatment and prevention, sharing the latest data across our diverse portfolio and pipeline of medicines that aim to address the evolving needs of the HIV community and leave no person living with HIV behind.
Media contacts
Media contact details for our global headquarters and USA. For press contacts in our local operating companies please visit our country websites.
In you have a media query please use our Contact our team form here.
Global Press Office
Catherine Hartley
Head of Global Communications ViiV Healthcare
Tel: +44 7909 00240
US Press Office
Audrey Abernathy
Head of ViiV US External Affairs & Communications
Tel: +1 919 605 4521
Social Media
NP-GBL-HVX-COCO-220039 | March 2022
